Comparing the cost-effectiveness of disease-modifying drugs for the first-line treatment of relapsing-remitting multiple sclerosis.
Goldberg, Lawrence D D, Edwards, Natalie C, Fincher, Contessa, Doan, Quan V, Al-Sabbagh, Ahmad, Meletiche, Dennis MVolume:
15
Year:
2009
Language:
english
Journal:
Journal of managed care pharmacy : JMCP
DOI:
10.0000/PMID19739877
File:
PDF, 371 KB
english, 2009